Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Spotlight on treatment of hirsutism

May 7, 1999

Genset strengthens obesity/metabolic disorder program

May 7, 1999

Mechanism of hypolipidemic effects and potential antiatherogenic effects of NTE-122

May 6, 1999

Low-dose aspirin enhances success of assisted reproduction

May 6, 1999

Different transdermal methods of estradiol administration produce different results

May 6, 1999

E.U. marketing approval granted for Cetrotide

May 6, 1999

Vitamin D3 analogues useful for osteoporosis, cancer and secondary hyperparathyroidism

May 6, 1999

Brazilian study evaluates potential utility of finasteride in women with hirsutism

May 5, 1999

Alendronate prevents LHRH analogue-induced bone loss

May 5, 1999

Aceclofenac is effective and well tolerated in women with primary dysmenorrhea

May 5, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...